B-I acquires private oncolytic-virus company for $245M: https://www.boehringer-ingelheim.com/press-release/boehringer-ingelheim-acquires-all-viratherapeutics-shares http://www.evaluate.com/vantage/articles/news/snippets/another-must-have-oncolytic-virus-asset-big-pharma